WO2010036005A3 - 리세드론산 또는 그의 염 및 비타민 ｄ를 포함하는 약학 조성물 - Google Patents

리세드론산 또는 그의 염 및 비타민 ｄ를 포함하는 약학 조성물 Download PDF

Info

Publication number
WO2010036005A3
WO2010036005A3 PCT/KR2009/005391 KR2009005391W WO2010036005A3 WO 2010036005 A3 WO2010036005 A3 WO 2010036005A3 KR 2009005391 W KR2009005391 W KR 2009005391W WO 2010036005 A3 WO2010036005 A3 WO 2010036005A3
Authority
WO
WIPO (PCT)
Prior art keywords
salt
vitamin
risedronic acid
pharmaceutical composition
provides
Prior art date
Application number
PCT/KR2009/005391
Other languages
English (en)
French (fr)
Other versions
WO2010036005A2 (ko
Inventor
김진선
이근혁
류종현
김재신
Original Assignee
한림제약 (주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42060257&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2010036005(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 한림제약 (주) filed Critical 한림제약 (주)
Priority to CN2009801355431A priority Critical patent/CN102149387A/zh
Publication of WO2010036005A2 publication Critical patent/WO2010036005A2/ko
Publication of WO2010036005A3 publication Critical patent/WO2010036005A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 리세드론산 또는 그의 염 및 비타민 D를 포함하는 골다공증 예방 또는 치료용 약학 조성물을 제공한다. 또한, 본 발명은 리세드론산 또는 그의 염 및 과립 형태의 비타민 D를 포함하는 혼합물을 타정하여 얻어진 경구용 정제; 및 콩기름 및 야자경화유의 혼합용제 중에 리세드론산 또는 그의 염 및 비타민 D를 균질하게 분산시켜 캡슐에 충진하여 얻어진 경구용 캡슐제를 제공한다.
PCT/KR2009/005391 2008-09-23 2009-09-22 리세드론산 또는 그의 염 및 비타민 ｄ를 포함하는 약학 조성물 WO2010036005A2 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009801355431A CN102149387A (zh) 2008-09-23 2009-09-22 含利塞膦酸或其盐和维生素d的药物组合物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2008-0093344 2008-09-23
KR1020080093344A KR101379664B1 (ko) 2008-09-23 2008-09-23 리세드론산 또는 그의 염 및 비타민 ｄ를 포함하는 약학 조성물

Publications (2)

Publication Number Publication Date
WO2010036005A2 WO2010036005A2 (ko) 2010-04-01
WO2010036005A3 true WO2010036005A3 (ko) 2010-07-15

Family

ID=42060257

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/005391 WO2010036005A2 (ko) 2008-09-23 2009-09-22 리세드론산 또는 그의 염 및 비타민 ｄ를 포함하는 약학 조성물

Country Status (3)

Country Link
KR (1) KR101379664B1 (ko)
CN (1) CN102149387A (ko)
WO (1) WO2010036005A2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160144663A (ko) 2015-06-09 2016-12-19 최숙 제제 및 이의 제조방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070038115A (ko) * 2004-07-23 2007-04-09 더 프록터 앤드 갬블 캄파니 리세드로네이트 조성물 및 그의 사용 방법
KR100822133B1 (ko) * 2006-11-06 2008-04-15 한미약품 주식회사 비타민 ｄ 또는 이의 유도체의 고체분산체 및비스포스포네이트를 포함하는, 골다공증 예방 또는 치료용복합제제
KR100844256B1 (ko) * 2007-03-23 2008-07-07 코오롱제약주식회사 리세드로네이트와 비타민 ｄ를 포함하는 대사성 골질환치료용 약제조성물 및 이의 제조방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070038115A (ko) * 2004-07-23 2007-04-09 더 프록터 앤드 갬블 캄파니 리세드로네이트 조성물 및 그의 사용 방법
KR100822133B1 (ko) * 2006-11-06 2008-04-15 한미약품 주식회사 비타민 ｄ 또는 이의 유도체의 고체분산체 및비스포스포네이트를 포함하는, 골다공증 예방 또는 치료용복합제제
KR100844256B1 (ko) * 2007-03-23 2008-07-07 코오롱제약주식회사 리세드로네이트와 비타민 ｄ를 포함하는 대사성 골질환치료용 약제조성물 및 이의 제조방법

Also Published As

Publication number Publication date
KR101379664B1 (ko) 2014-04-02
KR20100034294A (ko) 2010-04-01
WO2010036005A2 (ko) 2010-04-01
CN102149387A (zh) 2011-08-10

Similar Documents

Publication Publication Date Title
WO2014002051A3 (en) Complement pathway modulators and uses thereof
WO2014002058A3 (en) Complement pathway modulators and uses thereof
WO2008063910A3 (en) Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions
WO2008064353A3 (en) 7,8-saturated-4,5-epoxy-morphinanium analogs
WO2014009833A3 (en) Complement pathway modulators and uses thereof
MX2009003184A (es) Composiciones farmaceuticas que comprenden nilotinib o su sal.
MX336723B (es) Combinacion de (a) un inhibidor de fosfoinositido 3-cinasa y (b) un modulador de la ruta de ras/raf/mek.
WO2006011159A3 (en) Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
IL193357A0 (en) Metoprolol succinate e.r. tablets and methods for their preparation
PH12014502462A1 (en) Complement pathway modulators and uses thereof
WO2006000224A3 (en) Compositions comprising strontium and vitamin d and uses thereof
WO2011157722A3 (en) Solid ivabradine-containing composition
MX2009006447A (es) Composicion farmaceutica de liberacion sostenida a largo plazo que contiene suspension acuosa de bisfosfonato.
PH12020500525A1 (en) Manufacturing of pharmaceutical compositions
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
TW200718698A (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
EP1980255A4 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING SYNTHETIC STEROID DERIVATIVES SUCH AS TIBOLONE, MINERALS SUCH AS CALCIUM AND ACTIVE METABOLITE OF VITAMIN D (CALCITRIOL) FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS AND MENOPAUSE
MX2017013636A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas.
WO2010026467A3 (en) Controlled release tablet of a highly water soluble active agent such as levetiracetam, or citicoline
WO2009120389A8 (en) Oral and injectable formulations of tetracycline compounds
WO2010136035A3 (en) Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
WO2010036005A3 (ko) 리세드론산 또는 그의 염 및 비타민 ｄ를 포함하는 약학 조성물
EP2101742B8 (en) Pharmaceutical composition containing clopidogrel hydrogenesulphate of polymorph 1 form
GB0615105D0 (en) Novel compounds

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980135543.1

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09816398

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09816398

Country of ref document: EP

Kind code of ref document: A2